Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Shu T. Huang"'
Background: Establishing the species limits and resolving phylogenetic relationships are primary goals of taxonomists and evolutionary biologists. At present, a controversial question is about interspecific phylogenetic information in morphological f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678553ad1bef195c047955512db39272
Publikováno v:
Transfusion. 47:107-114
BACKGROUND: Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) is a diagnosis of exclusion when a patient presents with the sine qua non findings of thrombocytopenia and microangiopathic hemolytic anemia without an identifiable c
Publikováno v:
Artificial Cells, Blood Substitutes, and Biotechnology. 25:487-491
Coupling of an inert polymer to the surface of red cells was examined as a potential means of covering blood group antigens and producing cells that could serve as universal donor cells for transfusion. Effective blockade of red cell antigens was ach
Autor:
Stroncek D, Lennon Ss, Ho W, MacPherson Br, Petz Ld, Leach Mf, Gary Moroff, Garratty G, Shu T. Huang, Heal Jm
Publikováno v:
Transfusion. 32:633-640
A multi-site clinical study compared platelets chosen for refractory patients by prospective platelet crossmatching using stored donor platelets and HLA-based selection. Seventy-three patients who were refractory to random-donor platelets received tw
Publikováno v:
Journal of Biomedical Materials Research. 26:481-491
Various methods have been used for anastomosing, or attaching, two ends of a severed blood vessel together. The most common method, suturing, is tedious, can be time-consuming, and requires special training in microvascular surgery. Other methods, su
Publikováno v:
Laboratory Medicine. 31:541-543
We describe a case of life-threatening hemolytic anemia in which the cause of hemolysis was not readily apparent until a more complete clinical history was obtained. Data on drug exposures prior to the development of hemolysis should be part of the i
Publikováno v:
The American Journal of Medicine. 90:639-645
A case is described of a 75-year-old woman with a history of pulmonary tuberculosis and Waldenstrom's macroglobulinemia who developed an inhibitor of coagulation factor XIII while taking isoniazid. The patient presented with a subcutaneous hematoma o
Publikováno v:
Journal of clinical apheresis. 22(5)
While therapeutic plasma exchanges (TPEs) performed with 5% albumin are considered safe, concerns regarding venous access and hypocalcemic toxicity remain. We reviewed the frequency of complications during TPEs performed with 5% albumin supplemented
Publikováno v:
American journal of hematology. 82(2)
Autor:
Laura J. Pinderski, Barry K. Rayburn, Robert N. Brown, Marisa B. Marques, Salpy V. Pamboukian, Jose A. Tallaj, Shu T. Huang, S.M. Hubbard, David C. McGiffin, James F. George, R.B. Bourge, Raymond L. Benza, David C. Naftel, James K. Kirklin
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 25(3)
Photopheresis therapy (photo) has been advocated as a therapy to improve outcome after recalcitrant or severe rejection, but objective evidence of a beneficial effect has been elusive. This study examined the hypothesis that photo provides protection